Skip to main content
. 2022 Oct 13;13:1008778. doi: 10.3389/fimmu.2022.1008778

Figure 7.

Figure 7

RCSD1 differential expression in LUAD with different clinical subgroups. On (A) sample types, (B) individual cancer stages, (C) patient’s race, (D) patient’s gender, (E) patient’s age, (F) patient’s smoking habits, (G) histological subtypes, (H) nodal metastasis status and (I) TP53 mutation status. *, P < 0.05; **, P < 0.01; ***, P < 0.001.